Interestingly, acamprosate was again associated with higher odds of hepatic decompensation (OR 1.99; 95% CI 0.99–4.06), 14 although not fully statistically significant ( Table 1 ).
← all excerpts
Efficacy of Addiction Pharmacotherapy in Alcohol Use Disorder and Their Effects on Liver Health.
1
—
—